Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of a Nurse Navigator Program on Readmission Rates for Patients With Elevated BMI, COPD, CHF, Dialysis Use, and H/o Alcohol Abuse

NCT05592847 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05592847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05592847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of a Nurse Navigator Program on Readmission Rates for Patients With Elevated BMI, COPD, CHF, Dialysis Use, and H/o Alcohol Abuse
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
June 30, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholism, arthroplasty, replacement, hip, arthroplasty, replacement, knee, body mass index, heart failure, patient readmission, pulmonary disease, chronic obstructive, renal insufficiency